1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Czech Republic >
  5. Rafa Laboratories Acquires ExCEEd

M&A Deal Summary

Rafa Laboratories Acquires ExCEEd

On August 1, 2022, Rafa Laboratories acquired life science company ExCEEd

Acquisition Highlights
  • This is Rafa Laboratories’ 1st transaction in the Life Science sector.
  • This is Rafa Laboratories’ 1st transaction in Czech Republic.

M&A Deal Summary
Date 2022-08-01
Target ExCEEd
Sector Life Science
Buyer(s) Rafa Laboratories
Deal Type Add-on Acquisition

Target

ExCEEd

Prague, Czech Republic
ExCEEd is focused on innovative treatments for rare diseases and has extensive experience in launching innovative medicines in this field. The portfolio of ExCEEd Orphan includes products in therapeutic areas of hematology, neurology, immunology, and metabolic diseases. ExCEEd was founded in 2018 and is based in Prague, Czech Republic.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Rafa Laboratories

Jerusalem, Israel
Category Company
Founded 1937
Sector Healthcare Services
DESCRIPTION

Rafa Laboratories is a provider of an emergency solutions – medical countermeasures, supplying auto-injectors for government agencies, military forces and civilian populations. Rafa Laboratories was founded in 1937 and is based in Jerusalem, Israel.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Czech Republic M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal